1. Home
  2. Stock quotes
  3. Inhibikase Therapeutics
  4. Financial Statements
  5. Balance Sheet
  6. Long Term Debt Current
Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 2.95 -7.97%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Inhibikase Therapeutics Long Term Debt Current 2011-2024 | IKT

Annual Long Term Debt Current Inhibikase Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
150 K 146 K - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
150 K 146 K 148 K